Related Experiment Video
Updated: Jun 6, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
Deciphering and Targeting the ESR2-miR-10a-5p-BDNF Axis in the Prefrontal Cortex: Advancing Postpartum Depression
Fan Luo1,2,3, Liming Liu4, Mei Guo2
1The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Estrogen receptor 2 (ESR2), miR-10a-5p, and BDNF are key players in postpartum depression (PPD). Targeting this molecular pathway offers potential new treatments for PPD.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Postpartum depression (PPD) is a significant emotional disorder with complex causes.
- Estrogen fluctuations and estrogen receptor genes are implicated in PPD, but mechanisms are unclear.
Purpose of the Study:
- To investigate the molecular mechanisms of PPD involving ESR2, miR-10a-5p, and BDNF in the prefrontal cortex.
- To explore the therapeutic potential of targeting the ESR2-miR-10a-5p-BDNF pathway for PPD.
Main Methods:
- Animal behavioral studies in mice.
- Bioinformatics, in vivo experiments, and cell transfection.
- Primary neuron cultures and analysis of synaptic plasticity markers.
Main Results:
- Aberrant expression of ESR2, miR-10a-5p, and BDNF linked to depressive-like behavior in mice.
- ESR2 negatively regulates miR-10a, which negatively regulates BDNF.
- This pathway impacts synaptic plasticity and neuronal morphology.
Conclusions:
- The ESR2-miR-10a-5p-BDNF axis is crucial in PPD pathogenesis.
- Therapeutic interventions targeting this pathway show promise for PPD treatment.
- Estrogen receptor activity is a significant risk factor for PPD.
More Related Videos
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Depression: Overview